- Home
- Equipment
- usa washington
- vaccination
Show results for
Refine by
Vaccination Equipment Supplied In Usa Washington
12 equipment items found
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
Our TCR-antigen discovery capabilities may inform the design and development of next-generation vaccines. Adaptive has validated hundreds of immunogenic antigens that can be selected to design differentiated vaccines. Our platform is also used to detect and track vaccine-induced antigen-specific T cell responses that correlate ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-121 targets respiratory syncytial virus (RSV), a major cause of viral pneumonia for which no vaccine has been FDA approved. IVX-121 incorporates a stabilized prefusion F antigen licensed from NIAID/NIH (DS-Cav1; Science 2019). RSV F is known to undergo major structural changes that allow viral entry into the host cell, and during that process, critical protective epitopes are ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate for COVID-19, is a self-assembling protein nanoparticle that displays 60 copies of the SARS-CoV-2 spike (S) glycoprotein receptor-binding domain (RBD) in a highly immunogenic ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major contributor to acute respiratory infection and pneumonia with rates of pneumonia (Clinics in Chest Medicine 2017) and ...
Manufactured by:AstraZeneca based inCambridge, UNITED KINGDOM
Icosavax has initiated development of IVX-421, a SARS-CoV-2 vaccine candidate that incorporates an RBD antigen with critical mutations found in the SARS-CoV-2 beta ...
Manufactured by:Infitek Co., Ltd. based inJinan, CHINA
Pharmacy Refrigerators are designed with the unique needs of the pharmacy environment in mind and safely store vaccines, drugs, reagents, specimens, ...
Manufactured by:Infitek Co., Ltd. based inJinan, CHINA
Double Door Pharmacy Refrigerators are designed with the unique needs of the pharmacy environment in mind and safely store vaccines, drugs, reagents, specimens, ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
In the future, we may explore expanding our end-to-end capabilities for the development of cellular therapies and vaccines. TruTCR is summarized in the figure ...
Manufactured by:Infitek Co., Ltd. based inJinan, CHINA
It is suitable for pharmacies, pharmaceutical factories, hospitals, clinics, scientific research institutes, centers for disease prevention and control and other industrial institutions, used to store medicines, reagents, vaccines, biological products, ...
Manufactured by:AGC Biologics based inBothell, WASHINGTON (USA)
AGC Biologics has been manufacturing plasmid DNA (pDNA) for over 10 years. We are experienced in both clinical and commercial pDNA manufacturing. AGC Biologics has expanded its capabilities by extending services in hosts and plasmids (low and high copy pDNA expression systems) via a robust toolbox in process development with scales of 1L to 10L. These processes can easily be scaled up to 1000L ...
Manufactured by:Anavasi Diagnostics based inSeattle, WASHINGTON (USA)
The AscencioDx COVID-19 Molecular Detector is a rapid, highly accurate, easy-to-use and affordable clinical diagnostic platform used for performing molecular analysis of samples collected from patients in point-of-care (POC) settings utilizing the proprietary AscencioDx COVID-19 Test Kits. ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
Neutralizing antibodies defend healthy cells by interfering with the biological function of an invading virus. These antibodies may be used therapeutically to treat someone currently fighting the disease and provide passive immunity to people who have recently been exposed to ...